Rewrite Therapeutics

Intellia’s Rewrite Therapeutics buyout brings new precision to gene editing
MedCity News
Fri, 02/4/22 - 10:48 am
Intellia Therapeutics
Rewrite Therapeutics
gene editing
M&A